Related references
Note: Only part of the references are listed.Novel Clinical Features of Recurrent Human Respiratory Syncytial Virus Infections
Ikuko Yui et al.
JOURNAL OF MEDICAL VIROLOGY (2014)
The prevalence of increased serum IgE and Aspergillus sensitization in patients with COPD and their association with symptoms and lung function
Jianmin Jin et al.
RESPIRATORY RESEARCH (2014)
Respiratory Infections in Adults with Atopic Disease and IgE Antibodies to Common Aeroallergens
Aino Rantala et al.
PLOS ONE (2013)
Viral and Bacterial Interactions in the Upper Respiratory Tract
Astrid A. T. M. Bosch et al.
PLOS PATHOGENS (2013)
Does OM-85 BV prophylaxis trigger autoimmunity in IgA deficient children?
Neslihan Edeer Karaca et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2011)
OM-85 BV, an immunostimulant in pediatric recurrent respiratory tract infections: a systematic review
Urs B. Schaad
WORLD JOURNAL OF PEDIATRICS (2010)
Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype
R. H. Dougherty et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2009)
Allergic patients have more numerous and prolonged respiratory infections than nonallergic subjects
I. Cirillo et al.
ALLERGY (2007)
Double-blind study of OM-85 in patients with chronic bronchitis or mild chronic obstructive pulmonary disease
M. Soler et al.
RESPIRATION (2007)
Epidemiology and economic impact of rhinosinusitis
VK Anand
ANNALS OF OTOLOGY RHINOLOGY AND LARYNGOLOGY (2004)
Oral purified bacterial extracts in chronic bronchitis and COPD -: Systematic review
C Steurer-Stey et al.
CHEST (2004)
Immunostimulation with OM-85 in children with recurrent infections of the upper respiratory tract -: A double-blind, placebo-controlled multicenter study
UB Schaad et al.
CHEST (2002)
Acute upper airway infections
JV West
BRITISH MEDICAL BULLETIN (2002)
Safety and efficacy of two courses of OM-85 BV in the prevention of respiratory tract infections in children during 12 months
MD Gutiérrez-Tarango et al.
CHEST (2001)
Advances in immunology - Allergy and allergic diseases - First of two parts
AB Kay
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Levamisole induces interleukin-18 and shifts type 1/type 2 cytokine balance
CC Szeto et al.
IMMUNOLOGY (2000)